// App-Quantinova.ai

: Alternating the Administration of Ixazomib and Lenalidomide As Maintenance Therapy after Autologous Transplant for Multiple Myeloma

Researchers

Presenter

  • Leona A Holmberg

Principal Investigators

  • Damian J. Green

  • Sarah S Lee

  • Andrew J Cowan

Medical Centers

  • Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA

  • Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Peripheral Nervous System

  • Oncology (ONC)

  • Infectious Diseases (ID)

Disease

  • Peripheral neuropathy

  • Multiple Myeloma

  • Lung Cancer

  • Skin carcinoma

  • Bacterial Skin Infection

  • Influenza

  • Shingles

  • Coronavirus disease

  • Solid malignancies

  • Sepsis

  • Methicillin-resistant Staphylococcus aureus (MRSA) infection

Biomarkers

  • N-Acylethanolamine acid amidase

  • White Blood Cell

Drug/Treatment

  • Lenalidomide

  • Ixazomib

Outcome

  • N/A

Study Design

  • Randomized

  • Efficacy

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved